
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents
Keywords: مسکن مورفین; NPFF receptors; RF-amide peptides; Nociception; Morphine analgesia; Opioid-induced hyperalgesia; LH secretion; AUC; area-under-the-curve; CHO; chinese hamster ovary; FSH; follicle stimulating hormone; HI; hyperalgesia index; i.c.v.; intracerebroventricula